Page 63 - JSOM Fall 2024
P. 63
14. van der Bent SAS, Rauwerdink D, Oyen EMM, Maijer KI, Rust- 30. Lin C, Marquardt Y, Rütten S, et al. Macrophage-like rapid up-
emeyer T, Wolkerstorfer A. Complications of tattoos and per- take and toxicity of tattoo ink in human monocytes. Immunol-
manent makeup: overview and analysis of 308 cases. J Cosmet ogy. 2024;171(3):388–401. doi:10.1111/imm.13714
Dermatol. 2021;20(11):3630–3641. doi:10.1111/jocd.14498 31. Kluger N. Tattoo-associated uveitis with or without systemic sar-
15. Serup J, Hutton Carlsen K, Dommershausen N, et al. Identi- coidosis: a comparative review of the literature. J Eur Acad Der-
fication of pigments related to allergic tattoo reactions in 104 matol Venereol. 2018;32(11):1852–1861. doi:10.1111/jdv.15070
human skin biopsies. Contact Dermatitis. 2020;82(2):73–82. 32. Bose R, Sibley C, Fahim S. Granulomatous and systemic inflam-
doi:10.1111/cod.13423 matory reactions from tattoo ink: case report and concise re-
16. Serup J, Sepehri M, Hutton Carlsen K. Classification of tattoo view. SAGE Open Med Case Rep. 2020;8:2050313X20936036.
complications in a hospital material of 493 adverse events. Der- doi:10.1177/2050313X20936036
matology. 2016;232(6):668–678. doi:10.1159/000452148 33. Cunningham E, Dunn JP, Smit DP, Zierhut M. Tattoo-sssociated
17. Hutton Carlsen K, Serup J. Chronic tattoo reactions cause re- uveitis. Ocul Immunol Inflamm. 2021;29(5):835–837. doi:10.10
duced quality of life equaling cumbersome skin diseases. Curr 80/09273948.2021.2006517
Probl Dermatol. 2015:48:71–75. doi:10.1159/000369644 34. Juhas E, English JC 3rd. Tattoo-associated complications. J Pe-
18. Serup J, Hutton Carlsen K. Patch test study of 90 patients with diatr Adolesc Gynecol. 2013;26(2):125–129. doi:10.1016/j.jpag.
tattoo reactions: negative outcome of allergy patch test to baseline 2012.08.005
batteries and culprit inks suggests allergen(s) are generated in the 35. Abudu B, Erickson CP, Calame A, Cohen PR. Basal cell carci-
skin through haptenization. Contact Dermatitis. 2014;71:255– noma originating in a tattoo: case report and review of an uncom-
263. doi:10.1111/cod.12271 mon complication in tattoo recipients. Dermatol Pract Concept.
19. Schubert S, Kluger N, Schreiver I. Hypersensitivity to perma- 2019;9(4):265–270. doi:10.5826/dpc.0904a03
nent tattoos: Literature summary and comprehensive review of 36. Lorei NC, Lucas MJ, Logemann NF. Tattoo-induced hemangi-
patch tested tattoo patients 1997–2022. Contact Dermatitis. oma: An exploration of the potential for vascular proliferations
2023;88(5):331–350. doi:10.1111/cod.14291 following tattoo-related trauma. J Cutan Pathol. 2018;45(9):721–
20. De Cuyper C. Complications of cosmetic tattoos. Curr Probl Der- 724. doi: 10.1111/cup.13303.
matol. 2015:48:61–70. doi:10.1159/000369188 37. Baker PA, O’Dowd GJ, Khan IU. Dermatofibrosarcoma protuber-
21. Sepehri M, Jørgensen B, Serup J. Introduction of dermatome ans arising in a decorative tattoo. Sarcoma. 2005;9(1-2):37–41.
shaving as first line treatment of chronic tattoo reactions. J Der- 38. Monfrecola G, Fornaro L, Ascierto PA, et al. Could wide tattoo
matolog Treat. 2015;26(5):451–455. doi:10.3109/09546634.201 delay the early diagnosis of cutaneous melanoma? J Eur Acad Der-
4.999021 matol Venereol. 2023;37(9):e1117–e1118. doi:10.1111/jdv.19037
22. Chaisrimaneepan N, Khoruamklang T, Manupeerapun H. Pit- 39. Kluger N, Koljonen V. Tattoos, inks, and cancer. Lancet Oncol.
falls in laser-based device tattoo removal: a literature review. 2012;13(4):e161–e168. doi:10.1016/S1470-2045(11)70340-0
Skin The Journal of Cutaneous Medicine. 2024;8(2):1384–1395. 40. Nielsen C, Jerkeman M, Saxne Jöud A. Tattoos as a risk fac-
doi:10.25251/skin.8.2.4 tor for malignant lymphoma: a population-based case–control
23. Eklund Y, Rubin AT. Laser tattoo removal, precautions, and un- study. EClinicalMedicine. 2024;72:102649. doi:10.1016/j.eclinm.
wanted effects. Curr Probl Dermatol. 2015;48:88–96. doi:10.1159/ 2024.102649
000369191 41. Carlsen Hutton K, Sepehri M, Serup J. Tattooist-associated tat-
24. Szulia A, Antoszewski B, Zawadzki T, Kasielska-Trojan A. When too complications: “overworked tattoo,” “pigment overload” and
body art goes awry—severe systemic allergic reaction to red ink infections producing early and late adverse events. Dermatology.
tattoo requiring surgical treatment. Int J Environ Res Public 2020;236(3):208–215. doi: 10.1159/000501962
Health. 2022;19(17):10741. doi:10.3390/ijerph191710741 42. Pazos MD, Hu Y, Elani Y, Browning KL, Jiang N, Yetisen AK.
25. Bäumler W. Chemical hazard of tattoo colorants. Presse Med. Tattoo inks for optical biosensing in interstitial fluid. Adv Healthc
2020;49(4):104046. doi:10.1016/j.lpm.2020.104046 Mater. 2021;10(21):e2101238. doi:10.1002/adhm.202101238
26. Sepehri M, Hutton Carlsen K, Serup J. Papulo-nodular reactions 43. Dhond K, Hu Y, Yetisen AK. Dermal tattoo biosensors. Dermatol-
in black tattoos as markers of sarcoidosis: study of 92 tattoo reac- ogie (Heidelb). 2023;74(10):819–821. doi:10.1007/s00105-023-
tions from a hospital material. Dermatology. 2016;232(6):679– 05195-6
686. doi:10.1159/000453315 44. Alsing KK, Johannesen HH, Hansen RH, Serup J. Tattoo com-
27. Kluger N. Sarcoidosis on tattoos: a review of the literature from plications and magnetic resonance imaging: a comprehensive re-
1939 to 2011. Sarcoidosis Vasc Diffuse Lung Dis. 2013;30(2): view of the literature. Acta Radiol. 2020;61(12):1695–1700. doi:
86–102. 10.1177/0284185120910427
28. van der Bent SAS, de Winter RW, Wolkerstorfer A, Rustemeyer 45. Newell CF, Bridwell RE, Inman BL, Long B. Tattoo associated na-
T. Red tattoo reactions, a prospective cohort on clinical as- tive valve infective endocarditis. Am J Emerg Med. 2022:60:227.
pects. J Eur Acad Dermatol Venereol. 2019;33(10):e384–e386. e5-227.e7. doi:10.1016/j.ajem.2022.07.022
doi:10.1111/jdv.15677 46. Dougherty KD, Koch JR. Religious tattoos at one Christian uni-
29. Arl M, Nogueira DJ, Schveitzer Köerich J, Mottim Justino N, versity. Visual Studies. 2019;34(4):311–318. doi:10.1080/14725
Schulz Vicentini D, Gerson Matias W. Tattoo inks: Characteriza- 86X.2019.1687331
tion and in vivo and in vitro toxicological evaluation. J Hazard
Mater. 2019;364:548–561. doi:10.1016/j.jhazmat.2018.10.072 PMID: 39243405; DOI: 10.55460/CC3F-YNW2
Tattoo Inks: Health Risks and Biokinetics Explored | 61

